APA

Maus M. K. H., Grimminger P. P., Mack P. C., Astrow S. H., Stephens C., Zeger G., Hsiang J., Brabender J., Friedrich M., Alakus H., Hölscher A. H., Lara P., Danenberg K. D., Lenz H. J. & Gandara D. R. (20141001). KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies. : Lung cancer (Amsterdam, Netherlands).

Chicago

Maus M K H, Grimminger P P, Mack P C, Astrow S H, Stephens C, Zeger G, Hsiang J, Brabender J, Friedrich M, Alakus H, Hölscher A H, Lara P, Danenberg K D, Lenz H J and Gandara D R. 20141001. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies. : Lung cancer (Amsterdam, Netherlands).

Harvard

Maus M. K. H., Grimminger P. P., Mack P. C., Astrow S. H., Stephens C., Zeger G., Hsiang J., Brabender J., Friedrich M., Alakus H., Hölscher A. H., Lara P., Danenberg K. D., Lenz H. J. and Gandara D. R. (20141001). KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies. : Lung cancer (Amsterdam, Netherlands).

MLA

Maus M K H, Grimminger P P, Mack P C, Astrow S H, Stephens C, Zeger G, Hsiang J, Brabender J, Friedrich M, Alakus H, Hölscher A H, Lara P, Danenberg K D, Lenz H J and Gandara D R. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies. : Lung cancer (Amsterdam, Netherlands). 20141001.